|Articles|December 1, 2016
- Pharmaceutical Executive-12-01-2016
- Volume 36
- Issue 12
Pharmaceutical Executive, December 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive December 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Medical Game-Changers Beckonover 9 years ago
Investing in Africa: How to Do It Rightover 9 years ago
The Winning Edge in Emerging Marketsover 9 years ago
Paula Apsell: A Storied Life in Scienceover 9 years ago
Going to the Edgeover 9 years ago
Trump Administration Offers Relief, and Challenges, for Pharmaover 9 years ago
Executive Pay and Innovationover 9 years ago
Science: The Communal Languageover 9 years ago
Will NICE ‘Go Commercial’?over 9 years ago
Country Report: MexicoAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
Roche Enters $2.3 Billion Global Collaboration with Nurix Therapeutics to Co-Develop and Co-Commercialize Bexobrutideg
5